Dr Garegin Papoian
Dr Garegin Papoian is Co-founder and Chief Scientific Officer at Deep Origin, where he leads the development of hybrid AI-mechanistic drug discovery models. Previously a Monroe Martin Professor at the University of Maryland, his research spans computational chemistry and biophysics, including protein folding and dynamics. He received his PhD from Cornell University under Nobel Laureate Dr Roald Hoffmann and has authored more than 100 scientific publications.
ArticleWhy AI struggles with new drug targets – and how physics could help
Virtual screening can assess billions of compounds, but performance can fall on unfamiliar targets. Combining AI with molecular physics could help make predictions more reliable.